190 related articles for article (PubMed ID: 11823537)
1. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
[TBL] [Abstract][Full Text] [Related]
2. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention.
Attur MG; Dave M; Cipolletta C; Kang P; Goldring MB; Patel IR; Abramson SB; Amin AR
J Biol Chem; 2000 Dec; 275(51):40307-15. PubMed ID: 11007768
[TBL] [Abstract][Full Text] [Related]
3. Type II interleukin-1beta receptor: a candidate for gene therapy in human arthritis.
Amin AR
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S179-88. PubMed ID: 11039768
[TBL] [Abstract][Full Text] [Related]
4. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
5. Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro.
Wang J; Verdonk P; Elewaut D; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2003 Nov; 11(11):801-9. PubMed ID: 14609533
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
7. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
Chabaud M; Miossec P
Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes.
Cubitt CL; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):701-4. PubMed ID: 11222530
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes.
Martel-Pelletier J; Mineau F; Jolicoeur FC; Cloutier JM; Pelletier JP
J Rheumatol; 1998 Apr; 25(4):753-62. PubMed ID: 9558181
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
11. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis.
Honorati MC; Bovara M; Cattini L; Piacentini A; Facchini A
Osteoarthritis Cartilage; 2002 Oct; 10(10):799-807. PubMed ID: 12359166
[TBL] [Abstract][Full Text] [Related]
12. Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression.
Coulter KR; Wewers MD; Lowe MP; Knoell DL
Am J Respir Cell Mol Biol; 1999 May; 20(5):964-75. PubMed ID: 10226066
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.
Baragi VM; Renkiewicz RR; Jordan H; Bonadio J; Hartman JW; Roessler BJ
J Clin Invest; 1995 Nov; 96(5):2454-60. PubMed ID: 7593634
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
Wang J; Elewaut D; Veys EM; Verbruggen G
Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
[TBL] [Abstract][Full Text] [Related]
16. Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins.
Attur MG; Dave MN; Clancy RM; Patel IR; Abramson SB; Amin AR
J Immunol; 2000 Mar; 164(5):2684-91. PubMed ID: 10679109
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.
Palmer G; Mezin F; Juge-Aubry CE; Plater-Zyberk C; Gabay C; Guerne PA
Ann Rheum Dis; 2004 Jan; 63(1):43-9. PubMed ID: 14672890
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides.
Alstergren P; Benavente C; Kopp S
J Oral Maxillofac Surg; 2003 Oct; 61(10):1171-8. PubMed ID: 14586853
[TBL] [Abstract][Full Text] [Related]
19. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
20. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
Shlopov BV; Gumanovskaya ML; Hasty KA
Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
